Detalhe da pesquisa
1.
Etrasimod as induction and maintenance therapy for ulcerative colitis (ELEVATE): two randomised, double-blind, placebo-controlled, phase 3 studies.
Lancet
; 401(10383): 1159-1171, 2023 04 08.
Artigo
Inglês
| MEDLINE | ID: mdl-36871574
2.
Higher Intra-Abdominal Visceral Adipose Tissue Mass Is Associated With Lower Rates of Clinical and Endoscopic Remission in Patients With Inflammatory Bowel Diseases Initiating Biologic Therapy: Results of the Constellation Study.
Gastroenterology
; 165(4): 963-975.e5, 2023 10.
Artigo
Inglês
| MEDLINE | ID: mdl-37499955
3.
Managing Risks with Newer Oral Small Molecules in Patients with Inflammatory Bowel Diseases.
Curr Gastroenterol Rep
; 26(5): 145-156, 2024 May.
Artigo
Inglês
| MEDLINE | ID: mdl-38353899
4.
Comparative Persistence of Non-tumor Necrosis Factor (TNF) vs. TNF Antagonists for Post-operative Prophylaxis in Crohn's Disease (CD).
Dig Dis Sci
; 69(1): 235-245, 2024 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-38015321
5.
Inflammatory Bowel Disease Is Associated With an Increased Risk of Incident Acute Arterial Events: Analysis of the United Kingdom Biobank.
Clin Gastroenterol Hepatol
; 21(3): 761-770.e13, 2023 Mar.
Artigo
Inglês
| MEDLINE | ID: mdl-36075499
6.
ENTERPRET: A Randomized Controlled Trial of Vedolizumab Dose Optimization in Patients With Ulcerative Colitis Who Have Early Nonresponse.
Clin Gastroenterol Hepatol
; 2023 Nov 10.
Artigo
Inglês
| MEDLINE | ID: mdl-37951560
7.
Risk of Major Adverse Cardiovascular Events in Immune-Mediated Inflammatory Disorders on Biologics and Small Molecules: Network Meta-Analysis.
Clin Gastroenterol Hepatol
; 2023 Oct 10.
Artigo
Inglês
| MEDLINE | ID: mdl-37821035
8.
Combination Therapy With Immunomodulators Improves the Pharmacokinetics of Infliximab But Not Vedolizumab or Ustekinumab.
Clin Gastroenterol Hepatol
; 21(11): 2908-2917.e10, 2023 10.
Artigo
Inglês
| MEDLINE | ID: mdl-36280102
9.
Patients With Inflammatory Bowel Diseases and Higher Visceral Adipose Tissue Burden May Benefit From Higher Infliximab Concentrations to Achieve Remission.
Am J Gastroenterol
; 118(11): 2005-2013, 2023 11 01.
Artigo
Inglês
| MEDLINE | ID: mdl-37207314
10.
Current perspectives on pediatric inflammatory bowel disease focusing on transitional care management. What should we consider?
Gastroenterol Hepatol
; 46(2): 139-147, 2023 Feb.
Artigo
Inglês, Espanhol
| MEDLINE | ID: mdl-36243253
11.
Recommendations on the Appropriate Management of Steroids and Discharge Planning During and After Hospital Admission for Moderate-Severe Ulcerative Colitis: Results of a RAND Appropriateness Panel.
Am J Gastroenterol
; 117(8): 1288-1295, 2022 08 01.
Artigo
Inglês
| MEDLINE | ID: mdl-35416799
12.
Integrating new and emerging therapies into inflammatory bowel disease clinical practice.
Curr Opin Gastroenterol
; 38(4): 328-336, 2022 07 01.
Artigo
Inglês
| MEDLINE | ID: mdl-35762692
13.
Real-World Effectiveness and Safety of Tofacitinib in Crohn's Disease and IBD-U: A Multicenter Study From the TROPIC Consortium.
Clin Gastroenterol Hepatol
; 19(10): 2207-2209.e3, 2021 10.
Artigo
Inglês
| MEDLINE | ID: mdl-33068786
14.
Safety of Tofacitinib in a Real-World Cohort of Patients With Ulcerative Colitis.
Clin Gastroenterol Hepatol
; 19(8): 1592-1601.e3, 2021 08.
Artigo
Inglês
| MEDLINE | ID: mdl-32629130
15.
Development and Validation of a Test to Monitor Endoscopic Activity in Patients With Crohn's Disease Based on Serum Levels of Proteins.
Gastroenterology
; 158(3): 515-526.e10, 2020 02.
Artigo
Inglês
| MEDLINE | ID: mdl-31711925
16.
A Comprehensive Literature Review and Expert Consensus Statement on Therapeutic Drug Monitoring of Biologics in Inflammatory Bowel Disease.
Am J Gastroenterol
; 116(10): 2014-2025, 2021 10 01.
Artigo
Inglês
| MEDLINE | ID: mdl-34388143
17.
Association Between Vedolizumab Levels, Anti-vedolizumab Antibodies, and Endoscopic Healing Index in a Large Population of Patients with Inflammatory Bowel Diseases.
Dig Dis Sci
; 66(10): 3563-3569, 2021 10.
Artigo
Inglês
| MEDLINE | ID: mdl-33089483
19.
A Rare But Devastating Dermatologic Manifestation of Ulcerative Colitis.
Gastroenterology
; 164(6): 883-886, 2023 05.
Artigo
Inglês
| MEDLINE | ID: mdl-36336001
20.
Safety and Efficacy of Combination Treatment With Calcineurin Inhibitors and Vedolizumab in Patients With Refractory Inflammatory Bowel Disease.
Clin Gastroenterol Hepatol
; 17(3): 486-493, 2019 02.
Artigo
Inglês
| MEDLINE | ID: mdl-29751166